DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process i...
Gespeichert in:
| Veröffentlicht in: | DNA repair 2019-08, Vol.80, p.59-84 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 84 |
|---|---|
| container_issue | |
| container_start_page | 59 |
| container_title | DNA repair |
| container_volume | 80 |
| creator | Mirza-Aghazadeh-Attari, Mohammad Ostadian, Caspian Saei, Amir Ata Mihanfar, Ainaz Darband, Saber Ghazizadeh Sadighparvar, Shirin Kaviani, Mojtaba Samadi Kafil, Hossein Yousefi, Bahman Majidinia, Maryam |
| description | Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process in ovarian cancer necessitates having a detailed knowledge on a series of signaling mediators at the cellular and molecular levels. The complexity of the DDR process in ovarian cancer and how this process works in metastatic conditions is comprehensively reviewed. For evaluating the efficacy of therapeutic agents targeting DNA damage in ovarian cancer, we will discuss the components of this system including DDR sensors, DDR transducers, DDR mediators, and DDR effectors. The constituent pathways include DNA repair machinery, cell cycle checkpoints, and apoptotic pathways. We also will assess the potential of active mediators involved in the DDR process such as therapeutic and prognostic candidates that may facilitate future studies. |
| doi_str_mv | 10.1016/j.dnarep.2019.06.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_478563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1568786418303148</els_id><sourcerecordid>2253832493</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-c9e7dd7d1be000d8aaccbc10835b29d54b58173623c5bfbb44a40e8e097a9c263</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERX_gDRDykk2CnfgnZoFUFVqQKmABW6wb-87gYSYJtlPUt69HmQ4rWPna-o6PdD9CXnJWc8bVm03tB4g41Q3jpmaqZkw-IWdcqq7SnVRPj7MSp-Q8pQ1jXGqlnpHTljfaGN2ekR_vP19SDztYI42YpnFISGHw5TJBiDQMdLyDGGCgDgaH8S39OmYccoAtzRDXmBNdjZHmnxhhwjkHR1OOkHEdMD0nJyvYJnxxOC_I9-sP364-Vrdfbj5dXd5WTkiWK2dQe68975Ex5jsA53rHWdfKvjFeil52XLeqaZ3sV30vBAiGHTKjwbhGtRekWv5Nf3CaezvFsIN4b0cI9vD0q0xoxX41beHNP_kpjv5v6DHIBe-E5qIp2ddLtoC_Z0zZ7kJyuN3CgOOcbNPItmsbYfY1YkFdHFOKuDoWcWb3Fu3GLhbt3qJlyhaLJfbq0DD3O_TH0KO2ArxbACw7vQsYbXIBix4fIrps_Rj-3_AAYE2yYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2253832493</pqid></control><display><type>article</type><title>DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mirza-Aghazadeh-Attari, Mohammad ; Ostadian, Caspian ; Saei, Amir Ata ; Mihanfar, Ainaz ; Darband, Saber Ghazizadeh ; Sadighparvar, Shirin ; Kaviani, Mojtaba ; Samadi Kafil, Hossein ; Yousefi, Bahman ; Majidinia, Maryam</creator><creatorcontrib>Mirza-Aghazadeh-Attari, Mohammad ; Ostadian, Caspian ; Saei, Amir Ata ; Mihanfar, Ainaz ; Darband, Saber Ghazizadeh ; Sadighparvar, Shirin ; Kaviani, Mojtaba ; Samadi Kafil, Hossein ; Yousefi, Bahman ; Majidinia, Maryam</creatorcontrib><description>Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process in ovarian cancer necessitates having a detailed knowledge on a series of signaling mediators at the cellular and molecular levels. The complexity of the DDR process in ovarian cancer and how this process works in metastatic conditions is comprehensively reviewed. For evaluating the efficacy of therapeutic agents targeting DNA damage in ovarian cancer, we will discuss the components of this system including DDR sensors, DDR transducers, DDR mediators, and DDR effectors. The constituent pathways include DNA repair machinery, cell cycle checkpoints, and apoptotic pathways. We also will assess the potential of active mediators involved in the DDR process such as therapeutic and prognostic candidates that may facilitate future studies.</description><identifier>ISSN: 1568-7864</identifier><identifier>ISSN: 1568-7856</identifier><identifier>EISSN: 1568-7856</identifier><identifier>DOI: 10.1016/j.dnarep.2019.06.005</identifier><identifier>PMID: 31279973</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Apoptosis ; Cell Cycle Checkpoints ; DNA - metabolism ; DNA Damage ; DNA damage response ; DNA Repair ; Female ; Humans ; Medicin och hälsovetenskap ; Ovarian cancer ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - metabolism ; Signal Transduction</subject><ispartof>DNA repair, 2019-08, Vol.80, p.59-84</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-c9e7dd7d1be000d8aaccbc10835b29d54b58173623c5bfbb44a40e8e097a9c263</citedby><cites>FETCH-LOGICAL-c450t-c9e7dd7d1be000d8aaccbc10835b29d54b58173623c5bfbb44a40e8e097a9c263</cites><orcidid>0000-0002-6197-5392 ; 0000-0002-1186-3384</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dnarep.2019.06.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31279973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:141847142$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirza-Aghazadeh-Attari, Mohammad</creatorcontrib><creatorcontrib>Ostadian, Caspian</creatorcontrib><creatorcontrib>Saei, Amir Ata</creatorcontrib><creatorcontrib>Mihanfar, Ainaz</creatorcontrib><creatorcontrib>Darband, Saber Ghazizadeh</creatorcontrib><creatorcontrib>Sadighparvar, Shirin</creatorcontrib><creatorcontrib>Kaviani, Mojtaba</creatorcontrib><creatorcontrib>Samadi Kafil, Hossein</creatorcontrib><creatorcontrib>Yousefi, Bahman</creatorcontrib><creatorcontrib>Majidinia, Maryam</creatorcontrib><title>DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies</title><title>DNA repair</title><addtitle>DNA Repair (Amst)</addtitle><description>Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process in ovarian cancer necessitates having a detailed knowledge on a series of signaling mediators at the cellular and molecular levels. The complexity of the DDR process in ovarian cancer and how this process works in metastatic conditions is comprehensively reviewed. For evaluating the efficacy of therapeutic agents targeting DNA damage in ovarian cancer, we will discuss the components of this system including DDR sensors, DDR transducers, DDR mediators, and DDR effectors. The constituent pathways include DNA repair machinery, cell cycle checkpoints, and apoptotic pathways. We also will assess the potential of active mediators involved in the DDR process such as therapeutic and prognostic candidates that may facilitate future studies.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Cell Cycle Checkpoints</subject><subject>DNA - metabolism</subject><subject>DNA Damage</subject><subject>DNA damage response</subject><subject>DNA Repair</subject><subject>Female</subject><subject>Humans</subject><subject>Medicin och hälsovetenskap</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Signal Transduction</subject><issn>1568-7864</issn><issn>1568-7856</issn><issn>1568-7856</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS1ERX_gDRDykk2CnfgnZoFUFVqQKmABW6wb-87gYSYJtlPUt69HmQ4rWPna-o6PdD9CXnJWc8bVm03tB4g41Q3jpmaqZkw-IWdcqq7SnVRPj7MSp-Q8pQ1jXGqlnpHTljfaGN2ekR_vP19SDztYI42YpnFISGHw5TJBiDQMdLyDGGCgDgaH8S39OmYccoAtzRDXmBNdjZHmnxhhwjkHR1OOkHEdMD0nJyvYJnxxOC_I9-sP364-Vrdfbj5dXd5WTkiWK2dQe68975Ex5jsA53rHWdfKvjFeil52XLeqaZ3sV30vBAiGHTKjwbhGtRekWv5Nf3CaezvFsIN4b0cI9vD0q0xoxX41beHNP_kpjv5v6DHIBe-E5qIp2ddLtoC_Z0zZ7kJyuN3CgOOcbNPItmsbYfY1YkFdHFOKuDoWcWb3Fu3GLhbt3qJlyhaLJfbq0DD3O_TH0KO2ArxbACw7vQsYbXIBix4fIrps_Rj-3_AAYE2yYw</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Mirza-Aghazadeh-Attari, Mohammad</creator><creator>Ostadian, Caspian</creator><creator>Saei, Amir Ata</creator><creator>Mihanfar, Ainaz</creator><creator>Darband, Saber Ghazizadeh</creator><creator>Sadighparvar, Shirin</creator><creator>Kaviani, Mojtaba</creator><creator>Samadi Kafil, Hossein</creator><creator>Yousefi, Bahman</creator><creator>Majidinia, Maryam</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><orcidid>https://orcid.org/0000-0002-6197-5392</orcidid><orcidid>https://orcid.org/0000-0002-1186-3384</orcidid></search><sort><creationdate>20190801</creationdate><title>DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies</title><author>Mirza-Aghazadeh-Attari, Mohammad ; Ostadian, Caspian ; Saei, Amir Ata ; Mihanfar, Ainaz ; Darband, Saber Ghazizadeh ; Sadighparvar, Shirin ; Kaviani, Mojtaba ; Samadi Kafil, Hossein ; Yousefi, Bahman ; Majidinia, Maryam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-c9e7dd7d1be000d8aaccbc10835b29d54b58173623c5bfbb44a40e8e097a9c263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Cell Cycle Checkpoints</topic><topic>DNA - metabolism</topic><topic>DNA Damage</topic><topic>DNA damage response</topic><topic>DNA Repair</topic><topic>Female</topic><topic>Humans</topic><topic>Medicin och hälsovetenskap</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirza-Aghazadeh-Attari, Mohammad</creatorcontrib><creatorcontrib>Ostadian, Caspian</creatorcontrib><creatorcontrib>Saei, Amir Ata</creatorcontrib><creatorcontrib>Mihanfar, Ainaz</creatorcontrib><creatorcontrib>Darband, Saber Ghazizadeh</creatorcontrib><creatorcontrib>Sadighparvar, Shirin</creatorcontrib><creatorcontrib>Kaviani, Mojtaba</creatorcontrib><creatorcontrib>Samadi Kafil, Hossein</creatorcontrib><creatorcontrib>Yousefi, Bahman</creatorcontrib><creatorcontrib>Majidinia, Maryam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>DNA repair</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirza-Aghazadeh-Attari, Mohammad</au><au>Ostadian, Caspian</au><au>Saei, Amir Ata</au><au>Mihanfar, Ainaz</au><au>Darband, Saber Ghazizadeh</au><au>Sadighparvar, Shirin</au><au>Kaviani, Mojtaba</au><au>Samadi Kafil, Hossein</au><au>Yousefi, Bahman</au><au>Majidinia, Maryam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies</atitle><jtitle>DNA repair</jtitle><addtitle>DNA Repair (Amst)</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>80</volume><spage>59</spage><epage>84</epage><pages>59-84</pages><issn>1568-7864</issn><issn>1568-7856</issn><eissn>1568-7856</eissn><abstract>Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process in ovarian cancer necessitates having a detailed knowledge on a series of signaling mediators at the cellular and molecular levels. The complexity of the DDR process in ovarian cancer and how this process works in metastatic conditions is comprehensively reviewed. For evaluating the efficacy of therapeutic agents targeting DNA damage in ovarian cancer, we will discuss the components of this system including DDR sensors, DDR transducers, DDR mediators, and DDR effectors. The constituent pathways include DNA repair machinery, cell cycle checkpoints, and apoptotic pathways. We also will assess the potential of active mediators involved in the DDR process such as therapeutic and prognostic candidates that may facilitate future studies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31279973</pmid><doi>10.1016/j.dnarep.2019.06.005</doi><tpages>26</tpages><orcidid>https://orcid.org/0000-0002-6197-5392</orcidid><orcidid>https://orcid.org/0000-0002-1186-3384</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1568-7864 |
| ispartof | DNA repair, 2019-08, Vol.80, p.59-84 |
| issn | 1568-7864 1568-7856 1568-7856 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_478563 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Animals Apoptosis Cell Cycle Checkpoints DNA - metabolism DNA Damage DNA damage response DNA Repair Female Humans Medicin och hälsovetenskap Ovarian cancer Ovarian Neoplasms - genetics Ovarian Neoplasms - metabolism Signal Transduction |
| title | DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T03%3A31%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20damage%20response%20and%20repair%20in%20ovarian%20cancer:%20Potential%20targets%20for%20therapeutic%20strategies&rft.jtitle=DNA%20repair&rft.au=Mirza-Aghazadeh-Attari,%20Mohammad&rft.date=2019-08-01&rft.volume=80&rft.spage=59&rft.epage=84&rft.pages=59-84&rft.issn=1568-7864&rft.eissn=1568-7856&rft_id=info:doi/10.1016/j.dnarep.2019.06.005&rft_dat=%3Cproquest_swepu%3E2253832493%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2253832493&rft_id=info:pmid/31279973&rft_els_id=S1568786418303148&rfr_iscdi=true |